British researchers develop new cancer treatment
-
Last Update: 2020-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
develop a new cancer drug for cancer-related gene expression and have found a new method that could be used in prostate cancer testingThe new drug, called HXR9, developed by researchers at the University of Surrey, inhibits the activity of a gene called HOX, according to the Alpha Galileo science website, sponsored by the British Association for the Advancement of ScienceThe HOX gene is crucial to determining the properties of cells and tissues in early embryos, which are expressed in activated human cancer cells, the researchers saidThe new drug HXR9 blocks the activity of the HOX gene, killing cancer cells efficientlyRichard Morgan, who led the study, said the study showed that HXR9 had some therapeutic prospects for malignant melanoma, lung cancer and prostate cancerFurther analysis by the researchers showed that some of the proteins directed by the HOX gene in prostate cancer cells can be detected in the serumThe findings offer a potential new way to detect prostate cancer and its severity
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
